The Cigna Group (CI)
| Previous close | 358.10 |
| Open | 356.85 |
| Bid | 356.33 x 800 |
| Ask | 356.70 x 800 |
| Day's range | 350.43 - 356.85 |
| 52-week range | 253.95 - 370.64 |
| Volume | |
| Avg. volume | 1,375,595 |
| Market cap | 99.408B |
| Beta (5Y monthly) | 0.51 |
| PE ratio (TTM) | 28.04 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 5.60 (1.56%) |
| Ex-dividend date | 04 Sept 2024 |
| 1y target est | N/A |
- PR Newswire
The Cigna Group's "Community Vitality Project" Donates $75,000 to Nonprofits through Program Encouraging Fitness and Community Engagement
The Cigna Group (NYSE: CI) put out a challenge to its workforce this summer, inviting colleagues to join its first-ever Community Vitality Project, a nine-day challenge combining fun, fitness and fundraising. By logging more than 280,000 minutes of fitness activities and awarding their minutes spent moving, The Cigna Group employees helped determine how to allocate a collective $25,000 donation among three nonprofits: National Council for Mental Wellbeing, National Coalition for Homeless Veteran
- PR Newswire
Evernorth announces another step forward in lowering drug prices by making a Stelara biosimilar available at $0 out of pocket for patients early next year
Evernorth Health Services announced that it plans to have a Stelara biosimilar available for $0 out of pocket for eligible patients of its specialty pharmacy, Accredo, beginning in early 2025. The interchangeable biosimilar will be produced for Evernorth's affiliate private label distributor, Quallent Pharmaceuticals. It will be available at $0 out of pocket for most patients through Quallent's copay assistance program. This program is expected to save individual patients around $4,000 on averag
- PR Newswire
The Cigna Group Announces Appearance at the Morgan Stanley 22nd Annual Global Healthcare Conference
Global health company The Cigna Group (NYSE:CI) announced today that David Cordani, Chairman and Chief Executive Officer, will present at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 5, 2024, in New York, NY.
